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Abstract
Purpose: To improve ischemic stroke outcome prediction using imaging information from a prospective cohort who
received admission CT angiography (CTA).
Methods: In a prospectively designed study, 649 stroke patients diagnosed with acute ischemic stroke had admission NIH
stroke scale scores, noncontrast CT (NCCT), CTA, and 6-month outcome assessed using the modified Rankin scale (mRS)
scores. Poor outcome was defined as mRS.2. Strokes were classified as ‘‘major’’ by the (1) Alberta Stroke Program Early CT
Score (ASPECTS+) if NCCT ASPECTS was#7; (2) Boston Acute Stroke Imaging Scale (BASIS+) if they were ASPECTS+ or CTA
showed occlusion of the distal internal carotid, proximal middle cerebral, or basilar arteries; and (3) NIHSS for scores.10.
Results: Of 649 patients, 253 (39.0%) had poor outcomes. NIHSS, BASIS, and age, but not ASPECTS, were independent
predictors of outcome. BASIS and NIHSS had similar sensitivities, both superior to ASPECTS (p,0.0001). Combining NIHSS
with BASIS was highly predictive: 77.6% (114/147) classified as NIHSS.10/BASIS+ had poor outcomes, versus 21.5% (77/358)
with NIHSS#10/BASIS2 (p,0.0001), regardless of treatment. The odds ratios for poor outcome is 12.6 (95% CI: 7.9 to 20.0)
in patients who are NIHSS.10/BASIS+ compared to patients who are NIHSS#10/BASIS2; the odds ratio is 5.4 (95% CI: 3.5 to
8.5) when compared to patients who are only NIHSS.10 or BASIS+.
Conclusions: BASIS and NIHSS are independent outcome predictors. Their combination is stronger than either instrument
alone in predicting outcomes. The findings suggest that CTA is a significant clinical tool in routine acute stroke assessment.
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Introduction
The Screening Technology and Outcomes Project in Stroke
(STOPStroke) was prospective study whose purpose was to evaluate
advanced CT technology in ischemic stroke. Computed tomography
angiography (CTA) is a highly reliable method to detect occlusions of
the major cerebral arteries that are occluded in major ischemic stroke
syndromes. [1] Recent evidence suggests that it may also be useful in
identifying patients for thrombolytic therapy. [2] Yet despite its wide
availability, CTA has yet to be incorporated in the routine evaluation
of ischemic stroke patients or in stroke classification. Classification
instruments are valuable in ischemic stroke for prognosis, assessing
current practices, and evaluation of novel therapies. Clinical
instruments such as the National Institutes of Health Stroke Scale
(NIHSS) have proven value in predicting stroke outcomes and
assessing new treatments. [3] However, they do not provide direct
information on the initial event (arterial occlusion) that produces the
stroke syndrome and cerebral infarction. This limits their usefulness
in assessing the efficacy of therapies targeting vascular occlusion. [4]
The most widely employed imaging-based classification instru-
ment, the Alberta Stroke Program Early CT Score (ASPECTS)
system, is based on non-contrast CT (NCCT) [5] scoring of
parenchymal changes, but does not evaluate arterial occlusion. The
Boston Acute Stroke Imaging Scale (BASIS) combines vascular and
parenchymal imaging. [6] The analysis presented here compares
BASIS, ASPECTS and NIHSS classification instruments in
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30352prospectivelyenrolled patients intheSTOPStrokestudy.Allpatients
in the STOPstroke cohort underwent NCCT and CTA at the time
of initial evaluation for ischemic stroke. In addition, we assessed
whether stroke classification that involved combining neurological
and CTA information could improve stroke outcome prediction.
Methods
The prospective STOPStroke study received institutional review
board approval at both institutions, and was Health Insurance
Portability and Accountability Act compliant. All patients gave
informed written consent.
Patient cohort
742 consecutive patients presenting to the Massachusetts
General Hospital and the University of California at San
Francisco were prospectively enrolled in the Screening Technol-
ogy and Outcomes Project in Stroke (STOPStroke). Patients
suspected of having ischemic stroke within 24 hours of symptom
onset underwent emergency NCCT followed immediately by
CTA. Patients were excluded if iodinated contrast agent was
contraindicated or if there was intracranial hemorrhage. Demo-
graphic data, past medical history, and NIHSS scores were
obtained at admission. Modified Rankin scale (mRS) scores were
obtained at 6 months. [7,8,9] Favorable outcome was defined as
mRS=0–2, and poor outcome as mRS.2. Patients were
excluded if reliable mRS or NIHSS scores were not obtained.
Scanning procedures
NCCT and CTA were performed according to standard
protocols with multidetector CT scanners (LightSpeed; GE
Healthcare, Chalfont St. Giles, UK). [1] Representative NCCT
parameters were as follows: 120–140 kVp, 170 mA, 2-second scan
time, and 5-mm section thickness. Biphasic helical CTA scanning,
at the same head tilt, was performed immediately afterward, with
100–140 ml of contrast (Isovue; Bracco Diagnostics, Princeton,
NJ) at 3 ml/sec and a 25-second delay (40 seconds for patients in
atrial fibrillation). Contrast allergy and renal dysfunction are the
major relative contra-indications to contrast administration.
Parameters were 140 kVp, 220–250 mA, 0.8–1.0-second rotation,
2.5-mm section thickness, 1.25-mm reconstruction interval, 3.75-
mm/rotation table speed, and 0.75:1 pitch. Source images were
reconstructed into standardized maximum intensity projections of
the intracranial and extracranial vasculature.
CTA information results were available to the attending stroke
physicians. However, information is not available on how it may
have influenced treatment strategies.
Image Review
Image review was independently performed on a workstation
(Impax; Agfa Technical Imaging Systems, Richfield Park, NJ) by
neuroradiologists or neurologists (M.H.L., E.C., and W.J.K.) as
previously described. [10] Reviewers had information on patient
age, sex, and presenting clinical symptoms but were blinded to all
information after the initial emergency evaluation. [11] NCCT
images were reviewed first, followed by CTA. Disagreements were
resolved by consensus. The reviewers recorded both arterial
occlusions and brain areas with hypodensity considered to have
resulted from acute ischemia.
Stroke Severity Classification
The BASIS classification system was devised after all patients
were enrolled in STOPStroke, and was validated in 2 independent
retrospective studies. [6,12] Figure 1 illustrates patient classifica-
tion by the neuroimaging instruments evaluated here. Strokes were
classified as major by BASIS (BASIS+) if occlusion was identified
in the distal ICA, proximal MCA (M1 or M2 segments), or the
basilar artery, or if early ischemic changes were identified in 3 or
more ASPECTS territories in the anterior circulation, or as
previously described for posterior circulation ischemia. [6] Strokes
were classified as major by ASPECTS (ASPECTS+) if early
ischemic changes were identified in 3 or more ASPECTS
territories (ASPECTS score #7). [13] Based in part on
methodology used by Ingall et al, [14] a dichotomized NIHSS
was employed with major stroke classification given to patients
with an admission NIHSS of greater than 10 (designated
NIHSS.10).
Statistical analysis
Sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV) and accuracy for prediction of poor
outcome were determined for BASIS, ASPECTS, and dichoto-
mized NIHSS classifications. Comparisons between the sensitiv-
ities and specificities of classification systems for predicting poor
outcome were conducted using McNemar’s Test. [15] Other
comparisons were tested for statistical significance using 362o r
262 contingency tables, the t-test, odds ratios, or Wilcoxon’s Rank
Sum test, as appropriate. BASIS, NIHSS, ASPECTS, and patient
age were evaluated as predictors of poor outcome using forced
entry and stepwise multivariate logistic regression models (STATA
10, StataCorp LP).
Results
Cohort Characteristics
A total of 742 patients were enrolled. Ninety were excluded for
lack of a reliable mRS at 6 months and 3 were excluded for lack of
reliable NIHSS scores at admission. 649 patients formed the
analyzed cohort. Table 1 shows patient demographics, comorbid-
ities, and treatment. Significant differences between patients
classified as major strokes by the 3 classification instruments and
the remainder of the cohort included a higher prevalence of atrial
fibrillation, a higher median NIHSS, higher use of thrombolytic
therapy, and a much higher number of poor outcomes. Males
were less likely to have major strokes classified by all 3 instruments,
but this was statistically significant only for BASIS and ASPECTS
classification. Hypertension was significantly less prevalent in
strokes classified as major by ASPECTS only.
61% (396/649) of the patients had favorable outcomes and 39%
(253/649) had poor outcomes. Of the poor outcomes, 54.5%
(138/253) had NIHSS.10 and 59.7% (151/253) were BASIS+,
an insignificant difference (p=0.57). However, only 30.8% (78/
253) of patients that had poor outcomes were ASPECTS+. This
number was significantly lower than the other 2 classification
instruments (both p,0.0001).
BASIS+ patients had major artery occlusion and/or parenchy-
mal ischemic changes. Of the 253 BASIS+ patients, 200 had
arterial occlusions. Poor outcomes were found in 126 patients
(63%). While the proportion of patients with poor outcomes was
slightly higher than BASIS+ patients, there were 25 additional
patients that had poor outcomes identified by the BASIS
instrument.
Predictive Power of Classification Instruments
Table 2 displays the sensitivity, specificity, PPV, NPV, and
accuracy for prediction of poor outcomes by BASIS, ASPECTS,
and admission NIHSS.10. Classification by both BASIS and
dichotomized NIHSS is significantly more sensitive than AS-
Combined NIHSS/CTA Findings Predict Stroke Outcome
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BASIS (p,0.0001), but not more than dichotomized NIHSS. A
trend was found with BASIS slightly more sensitive than
dichotomized NIHSS (p=0.06). NIHSS.10 was significantly
more specific than BASIS (p=0.03). In univariate analysis, BASIS
(p=0.0217) and NIHSS (p,0.001) were both significant predic-
Figure 1. BASIS and ASPECTS classification. Patients are classified as BASIS+ if there are proximal cerebral artery occlusions observed on CTA or
a significant hypodensities on NCCT. The relevant arterial segment occlusions are depicted in drawing on the left and are defined as including the
following arteries: distal (intracranial) internal carotid artery (ICA), proximal (M1 or M2) middle cerebral artery (MCA) and/or basilar artery (BA). If none
of these arteries are observed to be occluded on the CTA, then the NCCT is scored using the scheme shown on the right for anterior circulation
strokes, which is also used for ASPECTS scoring. If a hypodensity deemed to be consistent with acute ischemic infarction is identified in one of the
cerebral regions shown, a point is deducted from the maximum score of 10. Patients with scores of 7 or less are both BASIS+ and ASPECTS+. BASIS+
classification for posterior circulation strokes in the absence of basilar artery occlusion requires bilateral pons or bilateral thalamus hypodensities.
doi:10.1371/journal.pone.0030352.g001
Table 1. Demographics, comorbidities, and treatment.
All patients NIHSS.10 NIHSS#10 p-value BASIS+ BASIS2
p-
value ASPECTS+ ASPECTS-
p-
value
n 649 188 461 n/a 249 400 n/a 121 528 n/a
Age (mean6SD) 68.2615.4 69.5616.6 67.8615.0 0.11 68.2616.8 68.2614.6 0.892 65.9618.3 68.8614.7 0.112
Male sex 330(50.8%) 88(46.8%) 242(52.5%) 0.189 108(43.4%) 222(55.5%) 0.001 50(41.3%) 280(53.0%) 0.02
NIHSS (median) 5 16 3 n/a 12 3 0.000 14 4 0.000
Diabetes 120(18.5%) 38(20.2%) 82(17.8%) 0.47 44(17.7%) 76(19.0%) 0.671 23(19.0%) 97(18.4%) 0.871
CAD 147(22.7%) 47(25.0%) 100(21.7%) 0.361 58(23.3%) 89(22.3%) 0.758 26(21.5%) 121(22.9%) 0.735
Atrial fibrillation 137 (21.1%) 59(31.4%) 78(16.9%) 0.000 75(30.1%) 62(15.5%) 0.000 36(29.8%) 101(19.1%) 0.01
Smoking 201(31.0%) 51(27.1%) 150(32.5%) 0.176 74(29.7%) 127(31.8%) 0.586 36(29.8%) 165(31.3%) 0.748
Hyperlipid 190(29.3%) 52(27.7%) 138(29.9%) 0.563 76(30.5%) 114(28.5%) 0.582 36(29.8%) 154(29.2%) 0.898
IV tPA 101(15.6%) 64(34.0%) 37(8.0%) 0.000 69(27.7%) 32(8.0%) 0.000 34(28.1%) 67(12.7%) 0.000
IA thrombolysis 31(4.8%) 29(15.4%) 2(0.4%) 0.000 31(12.4%) 0(0.0%) 0.000 12(9.9%) 19(3.6%) 0.003
doi:10.1371/journal.pone.0030352.t001
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logistic models, BASIS, NIHSS, and patients’ age were indepen-
dent predictors of poor outcome (all p,0.004), however
ASPECTS was not (p=0.18). The odds ratios for ASPECTS,
BASIS, NIHSS, and age were 1.560.5, 2.160.5, 6.361.5, and
1.160.01, respectively. There were no significant interactions
between each of these variables.
Combined NIHSS and BASIS Classification Instrument
Because BASIS and NIHSS were shown by logistic regression to
be independently significant predictors of poor outcome, a
classification scheme combining BASIS and NIHSS was evaluat-
ed. 77.8% (505/649) of all patients were classified as NIHSS#10
and BASIS2 or NIHSS.10 and BASIS+. The predictive power
of this combined instrument is displayed in Figure 2. Of patients
classified as NIHSS#10 and BASIS2, 78.5% (281/358) had good
outcomes regardless of treatment, which is a significantly higher
proportion than patients in the other groups (362 contingency
p,0.0001; vs. each class p,0.0001). Conversely, 77.6% (114/147)
with NIHSS.10 and BASIS+ had poor outcomes (vs. each class
p,0.0001) also without regard to treatment. The odds ratios for
poor outcome is 12.6 (95% CI: 7.9 to 20.0) in patients who are
NIHSS.10/BASIS+ compared to patients who are NIHSS#10/
BASIS2; the odds ratio is 5.4 (95% CI: 3.5 to 8.5) when compared
to patients who are only NIHSS.10 or BASIS+.
IV tPA, Endovascular Therapy, Classification and
Outcomes
The effect of thrombolytic therapy on outcome prediction by
the 3 classification instruments was evaluated. 101 patients (15.6%)
received IV tPA (86 received IV tPA only, 15 received both IV
tPA and endovascular therapy). 51 of these patients had poor
outcomes. The proportion of poor outcomes in patients who
received IV tPA was significantly higher than the proportion of
poor outcomes in patients who did not receive tPA (50.5% vs.
32.8% (180/548); p,0.001). However, 342 of the untreated
patients had mild clinical symptoms (NIHSS#5). If this subset is
removed, a slightly higher proportion of patients who received IV
tPA had good outcomes (43/91; 47.3%) than those who did not
receive this treatment (92/206; 44.7%), but the difference was not
significant (p=0.68). The majority of the 101 patients who
received IV tPA were BASIS+ (69/101) or NIHSS.10 (64/101),
while only about one-third were ASPECTS+ (34/101). Despite IV
tPA treatment, most BASIS+ (39/69, 56.5%), NIHSS.10 (41/64,
64%), and ASPECTS+ (21/34, 62%) patients had poor outcomes.
A total of 31 patients (4.8%) underwent endovascular therapy
including 15 who received IV tPA prior to the procedure. Patients
in this group had the worst outcomes with 23 (74.2%) having
mRS.2 at 6 months. These patients also had the most severe
symptoms with a median NIHSS of 18, compared to a median
NIHSS of 5 for the remainder of the cohort (p,0.001). With
respect to the classification instruments, 31/31 were BASIS+, 14/
31 were ASPECTS+ and 29/31 were NIHSS.10.
Discussion
Contemporary CT can rapidly produce images that reliably
depict major cerebral artery occlusion. The STOPStroke study
demonstrates that CTA acquisition does not hinder stroke patient
management, and that additional information provided by CTA
may enhance patient care. Combining the imaging-based BASIS
classification instrument with the NIHSS substantially enhances
outcome prediction, and may help in identifying subsets of patients
that are more or less likely to benefit from therapy.
Among vessel imaging methods, CTA is more reliable than
MRA because it is less susceptible to motion, pulsation, flow, and
other artifacts, and more reliable than ultrasound because the
latter is often limited in coverage due to calcification/tortuous or
deep vessels/overlying bone. There were no relevant side effects of
the iodinated intravenous CT contrast in this patient cohort, as
reported in a publication obtained in the same patient cohort. [16]
That there is a clinical need for refinement of the existing
classification instruments used in the evaluation and therapeutic
management of acute stroke patients - most notably the NIH
stroke scale and ASPECT scores - is supported by the current
DIAS III and IV study designs, which use CTA as a critical
component of patient selection. [17]NIHSS has been shown to
predict length of stay, hospital cost, clinical outcomes, and hospital
discharge disposition. [3,18,19,20] However, the NIHSS and
similar instruments do not identify the occluded artery, the
initiating event that leads to neurological symptoms. As noted by
Caplan, the lack of information on arterial occlusion has likely
limited progress in the treatment of ischemic stroke. [4]
Neuroimaging overcomes this limitation. Several stroke classifica-
tion systems that employ imaging have been described.
[5,21,22,23] However, BASIS [6] is the only instrument that
incorporates angiographic data, is independent of whether CT or
MRI is used, and classifies patients with either anterior or
posterior circulation strokes. The use of CTA has previously been
shown to predict outcomes, [24,25,26] and BASIS was built upon
that foundation.
The majority of patients in this study had mild neurological
symptoms (54.6% had NIHSS 0–5), and good outcomes (61%).
Patients classified with severe strokes by all 3 instruments were
found to have a higher prevalence of atrial fibrillation, higher use
of thrombolytic therapy, and a much higher proportion of poor
outcomes. BASIS and NIHSS were more sensitive than AS-
PECTS for prediction of poor outcomes, probably due to the poor
sensitivity of NCCT for identifying early ischemia. While BASIS+
and NIHSS.10 have similar power in predicting poor outcomes,
they are not equivalent, and they are independent predictors of
poor outcomes. Some have suggested that NIHSS.10 is
predictive major artery occlusion. This was not found to be the
case in the present study in which 185 patients had NIHSS.10,
but only122 of these had a major artery occlusion.
Combined NIHSS/BASIS classification is substantially more
powerful in predicting outcomes than any single classification
instrument. Close to 80% of all patients were dual-classified as
either NIHSS#10/BASIS2 or NIHSS.10/BASIS+, with nearly
80% of NIHSS#10/BASIS2 patients having a good outcomes
and a similar percentage of NIHSS.10/BASIS+ patients having
poor outcomes, regardless of treatment. The potential prognostic
clinical utility of this classification is substantial as indicated by the
odds ratio of a poor outcome of over 12 in NIHSS.10/BASIS+
Table 2. Prediction of poor outcome.
NIHSS.10 BASIS ASPECTS
Sensitivity 54.5 59.7 30.0
Specificity 87.4 75.3 88.6
PPV 73.4 60.6 62.8
NPV 75.1 74.5 66.5
Accuracy 74.6 69.2 65.8
doi:10.1371/journal.pone.0030352.t002
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BASIS2.
The predictive efficacy of combining NIHSS and BASIS into a
single classification instrument is reasonable given our current
understanding of ischemic stroke. BASIS is a measure of the early
physiological abnormalities underlying the ischemic stroke process
while the NIHSS reflects the functional significance of the same
process. It is the amalgamation of this complementary information
that makes the combined classification scheme potent in predicting
the functional status of the patient several months after the event.
For example, a NIHSS.10/BASIS+ classification indicates that
the pathophysiology of a major stroke is present (either occlusion
of a major cerebral artery, substantial parenchymal injury or
both), and that this abnormal physiology is functionally severe. In
the absence of therapy, the expected outcome would be a major
cerebral infarction producing a severe functional disability.
The improvement of predictive power in ischemic stroke
through the combination of imaging information with clinical
assessments to has been previously demonstrated in transient
ischemic attacks by 2 groups. [27,28] Both groups have shown that
the presence of a DWI abnormality greatly improves the
prediction of the early risk of stroke after TIA. The similarity to
the work presented here is that imaging provides physiological
information that is complementary to the clinical evaluation.
The STOPstroke study has demonstrated that CT angiography
can be performed while maintaining a high percentage of patients
that receive thrombolytic therapy, and the imaging data can be
used for classification that can predict outcomes independent of
neurological evaluation. Classifications by NIHSS and BASIS are
superior to ASPECTS, and the combination of NIHSS and BASIS
instruments is substantially more powerful than any single
instrument. These observations may be explained by the early
identification by neuroimaging of stroke pathophysiology that
produces functionally severe symptoms, a hypothesis that merits
further investigation. The use of combined NIHSS/BASIS
classification may permit the design of efficient prospective trials
of stroke treatment.
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